Description

Flavamed (ambroxol hydrochloride) Forte Solution Against Cough 30 mg/5 ml. 100 ml

Ingredients

Active ingredient: Ambroxol hydrochloride.
Other ingredients: [list other ingredients if applicable].

Dosage

Recommended dosage: Adults and children over 12 years: 10 ml 3 times a day. Children 6-12 years: 5 ml 2-3 times a day. [Adjust dosage based on age and weight].

Indications

Flavamed Forte Solution is indicated for the treatment of productive cough to help clear mucus and phlegm from the airways.

Contraindications

Do not use Flavamed Forte Solution if you are allergic to ambroxol or any other ingredients in the product. Consult a healthcare professional before use if pregnant or breastfeeding.

Directions

Shake well before use. Take the prescribed dose orally with water. Do not exceed the recommended dosage. Consult a doctor for use in children under 6 years.

Scientific Evidence

Flavamed (ambroxol hydrochloride) has been extensively studied for its efficacy in treating respiratory conditions. Research published in the journal Pulmonary Pharmacology & Therapeutics demonstrated the mucolytic and expectorant properties of ambroxol, making it a valuable agent in managing respiratory disorders.

Additional Information

Flavamed Forte Solution is well-tolerated and has a favorable safety profile. It is commonly prescribed by healthcare professionals for the relief of cough associated with conditions such as bronchitis, asthma, and COPD. Always follow the recommended dosage and consult a healthcare provider if symptoms persist or worsen.

Pharmacological Effects: Ambroxol hydrochloride works by thinning and loosening mucus in the airways, making it easier to cough up. It also stimulates the production of surfactant, a substance that helps keep the lungs clear of debris.

Clinical Trials: Clinical trials have shown that ambroxol hydrochloride is effective in improving mucus clearance and reducing cough frequency in patients with respiratory conditions. A study published in the journal Respiration investigated the efficacy of ambroxol in patients with chronic bronchitis and found significant improvements in cough and sputum production.